Pay in 4 interest-free payments of $6.81 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Statements Data availability statement The raw data supporting the conclusion of this article will be made available by the authors, without undue reservation
PL BioScience has advanced an oral BPC-157 formulation (designated PL-10) to Phase II clinical trials for inflammatory bowel disease representing the most clinically advanced human development of oral BPC-157 to date.3 Human peer-reviewed results from these trials are pending, but the preclinical rationale is strong
If youre interested in exploring BPC-157 or have questions about incorporating it into your wellness routine, our team is here to provide expert guidance and support
We couldn't find that product
US$ 21.47
US$ 29.07
US$ 23.64
US$ 25.56
